Metabolism of [3-¹⁴C] coumarin by human liver microsomes

References

• Camus A.-M., Geneste D., Honkakoski P., Béréziat J.-C., Henderson C. J., Wolf C. R., Bartsch H., Lang M. A. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Molecular Carcinogenesis 1993; 7: 268–275
   PubMed Web of Science ®Google Scholar
• Cholerton S., Idle M. E., Vas A., Gonzalez F. J., Idle J. R. Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorimetric method for the determination of 7-hydroxycoumarin in human urine. Journal of Chromatography 1992; 575: 325–330
   PubMed Web of Science ®Google Scholar
• Cohen A. J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food and Chemical Toxicology 1979; 17: 277–289
   Web of Science ®Google Scholar
• Crespi C. L., Penman B. W., Leakey J. A. E., Arlotto M. P., Stark A., Parkinson A., Turner T., Steimel D. T., Rudo K., Davies R. L., Langenbach R. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 1990; 11: 1293–1300
   PubMed Web of Science ®Google Scholar
• Egan D., O'Kennedy R., Moran E., Cox D., Prosser E., Thornes R. D. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metabolism Reviews 1990; 22: 503–529
   PubMed Web of Science ®Google Scholar
• Fentem J. H., Fry J. R. Metabolism of coumarin by rat, gerbil and human liver microsomes. Xenobiotica 1992; 22: 357–367
   PubMed Web of Science ®Google Scholar
• Fentem J. H., Fry J. R., Whiting D. A. o-Hydroxyphenylacetaldehyde: a major novel metabolite of coumarin formed by rat, gerbil and human liver microsomes. Biochemical and Biophysical Research Communications 1991; 179: 197–203
   PubMed Web of Science ®Google Scholar
• Feuer G. The metabolism and biological actions of coumarins. Progress in Medicinal Chemistry, G. P. Ellis, G. B. West. North Holland, Amsterdam 1974; Vol. 10: 85–158
   Google Scholar
• Forrester L. M., Henderson C. J., Glancey M. J., Back D. J., Park B. K., Ball S. E., Kitteringham N. R., McLaren A. W., Miles J. S., Skett P., Wolf C. R. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal 1992; 281: 359–368
   PubMed Web of Science ®Google Scholar
• Gangolli S. D., Shilling W. H., Grasso P., Gaunt I. F. Studies on the metabolism and hepatoxicity of coumarin in the baboon. Biochemical Society Transactions 1974; 2: 310–312
   Google Scholar
• Henderson C. J., Wolf C. R. Immunodetection of proteins by Western blotting. Methods in Molecular Biology, M. Manson. Humana, New Jersey 1992; Vol. 10: 221–233
   Google Scholar
• Kaighen M., Williams R. T. The metabolism of [3-14C] coumarin. Journal of Medicinal Chemistry 1961; 3: 25–43
   Web of Science ®Google Scholar
• Lake B. G. Investigations into the mechanism of coumarin-induced hepatotoxicity in the rat. Archives of Toxicology 1984, Suppl. 7: 16–29
   PubMed Web of Science ®Google Scholar
• Lake B. G., Gaudin H., Price R. J., Walters D. G. Metabolism of [3-14C] coumarin to polar and covalently bound products by hepatic microsomes from the rat Syrian hamster, gerbil and humans. Food and Chemical Toxicology 1992b; 30: 105–115
   PubMed Web of Science ®Google Scholar
• Lake B. G., Gray T. J. B., Evans J. G., Lewis D. F. V., Beamand J. A., Hue K. L. Studies on the mechanism of coumarin-induced toxicity in rat hepatocytes: comparison with dihydrocoumarin and other coumarin metabolites. Toxicology and Applied Pharmacology 1989; 97: 311–323
   PubMed Web of Science ®Google Scholar
• Lake B. G., Osborne D. J., Walters D. G., Price R. J. Identification of o-hydroxyphenylacetaldehyde as a major metabolite of coumarin in rat hepatic microsomes. Food and Chemical Toxicology 1992a; 30: 99–104
   PubMed Web of Science ®Google Scholar
• Lush I. E., Andrews K. M. Genetic variation between mice in their metabolism of coumarin and its derivatives. Genetical Research 1978; 31: 177–186
   PubMed Web of Science ®Google Scholar
• Maurice M., Emiliani S., Dalet-Beluche I., Derancourt J., Lange R. Isolation and characterization of cytochrome P450 of the IIA subfamily from human liver microsomes. European Journal of Biochemistry 1991; 200: 511–517
   PubMedGoogle Scholar
• Miles J. S., Bickmore W., Brook J. D., McLaren A. W., Meehan R., Wolf C. R. Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity. Nucleic Acids Research 1989; 17: 2907–2917
   PubMed Web of Science ®Google Scholar
• Miles J. S., McLaren A. W., Forrester L. M., Glancey M. J., Lang M. A., Wolf C. R. Identification of the human liver cytochrome P450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal 1990; 267: 365–371
   PubMed Web of Science ®Google Scholar
• Negishi M., Lindberg R., Burkhart B., Ichikawa T., Honkakoski P., Lang M. Mouse steroid 15α-hydroxylase gene family: identification of Type II P45015α as coumarin 7-hydroxylase. Biochemistry 1989; 28: 4169–4172
   PubMed Web of Science ®Google Scholar
• Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O., Okuda K., Nebert D. W. The P450 subfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology 1993; 12: 1–51
   PubMed Web of Science ®Google Scholar
• Pearce R., Greenway D., Parkinson A. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Archives of Biochemistry and Biophysics 1992; 298: 211–225
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Raunui H., Rautio A., Mäenpää J., Lang M. A. Coumarin 7-hydroxylase: characteristics and regulation in mouse and man. Journal of the Irish Colleges of Physicians and Surgeons 1993; 22(Suppl. 1)24–28
   Google Scholar
• Pelkonen O., Sotaniemi E. A., Ahokas J. T. Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. British Journal of Clinical Pharmacology 1985; 19: 59–66
   PubMed Web of Science ®Google Scholar
• Peters M. M. C. G., Walters D. G., van Ommen B., van Bladeren P. J., Lake B. G. Effect of inducers of cytochrome P450 on the metabolism of [3-14C] coumarin by rat hepatic microsomes. Xenobiotica, 21: 499–514
   PubMed Web of Science ®Google Scholar
• Raunio H., Syngelmä T., Pasanen M., Juvonen R., Honkakoski P., Kairaluoma M. A., Sotaniemi E., Lang M. A., Pelkonen O. Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochemical Pharmacology 1988; 37: 3889–3895
   PubMed Web of Science ®Google Scholar
• Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 1992; 2: 227–233
   PubMedGoogle Scholar
• Salonpää P., Hakkola J., Pasanen M., Pelkonen O., Vähäkangas K., Battula N., Nouso K., Raunio H. Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. European Journal of Pharmacology 1993; 221: 95–102
   Google Scholar
• Shilling W. H., Crampton R. F., Longland R. C. Metabolism of coumarin in man. Nature 1969; 221: 664–665
   PubMed Web of Science ®Google Scholar
• Soine T. O. Naturally occurring coumarins and related physiological activities. Journal of Pharmaceutical Sciences 1964; 53: 231–264
   PubMed Web of Science ®Google Scholar
• Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyses coumarin 7-hydroxylation in human liver microsomes. Biochemistry 1990; 29: 1322–1329
   PubMed Web of Science ®Google Scholar
• Yamazaki H., Inui Y., Yun C.-H., Guengerich F. P., Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 1992; 13: 1789–1794
   PubMed Web of Science ®Google Scholar
• Yun C.-H., Shimada T., Guengerich F. P. Purification and characterization of human liver microsomal cytochrome P450 2A6. Molecular Pharmacology 1991; 40: 679–685
   PubMed Web of Science ®Google Scholar